Saturday 17 October 2026
Export BFLY’s income statement to Excel — free account
Butterfly Network, Inc.
BFLY Healthcare Medical Devices
Butterfly Network, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $97.6 million, up 19.0% from fiscal 2024. In the quarter to June 2026, revenue grew 39.5%, EPS grew 16.7% and free cash flow fell 113.9%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
7.25
0.60
−7.64%
Follow BFLY
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Jan '22 | Dec '21 | Jan '21 | Dec '20 | Jan '20 | Dec '19 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 5 | 3 | 2 | — | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
9.62 | 8.05 | 3.30 | 6.37 | 19.03 | 18.59 | 2.51 | 2.59 | 0.00 | 0.00 |
Altman Z-Score |
1.56 | 0.19 | (2.40) | 0.73 | — | 4.54 | — | (6.70) | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(5.51) | (6.43) | (4.26) | 0.75 | — | 4.38 | — | (15.64) | — | — |
Beneish M-Score |
(3.30) | (2.93) | (2.07) | (2.72) | — | (3.62) | — | — | — | — |
P/Operating CF |
103.98 | (211.68) | (16.62) | (16.20) | (27.83) | (27.18) | (5.62) | (5.81) | (3.03) | (3.03) |
P/B ratio |
4.79 | 3.91 | 0.99 | 1.44 | 2.66 | 2.60 | 0.00 | 0.00 | 11.95 | 11.95 |
Price to Tangible BV |
4.98 | 4.13 | 1.04 | 1.44 | 2.66 | 2.60 | 0.00 | 0.00 | 11.95 | 11.95 |
EV/Sales |
8.63 | 7.62 | 2.08 | 3.87 | 12.71 | 12.69 | 2.37 | 2.46 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(66.34) | (15.00) | (1.39) | (1.68) | (4.20) | (4.20) | (1.34) | (1.39) | 0.00 | 0.00 |
EV/FCF |
(52.50) | (14.10) | (1.31) | (1.51) | (4.04) | (4.03) | (1.30) | (1.35) | 0.00 | 0.00 |
Quick Ratio |
2.72 | 2.27 | 3.34 | 4.92 | 4.92 | 8.73 | 8.73 | 0.95 | 0.95 | — |
Current Ratio |
3.83 | 3.99 | 5.22 | 6.96 | 6.96 | 10.27 | 10.27 | 1.40 | 1.40 | — |
Net Debt/EBITDA |
1.92 | 1.39 | 1.00 | 1.27 | 1.12 | 2.22 | 2.13 | 0.04 | 0.04 | 0.00 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 7.18% | 0.00% | 4.84% | 36.62% | 36.62% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.00 | 0.06 | (0.15) | (54.22) | 0.00 |
Asset Turnover |
0.35 | 0.29 | 0.18 | 0.15 | 0.00 | 0.17 | 0.00 | 0.31 | 0.00 | 0.00 |
Operating CF/Net income |
0.16 | 0.58 | 0.74 | 1.00 | 1.00 | 5.84 | 5.84 | 0.50 | 0.51 | 1.21 |
Capex/Depreciation |
(0.41) | (0.26) | (0.55) | (3.07) | 0.00 | (3.77) | 0.00 | (1.81) | 0.00 | (5.89) |
Interest Coverage |
(58.00) | (59.01) | — | (96,510.00) | (113.02) | (296.05) | (145.61) | (141.65) | (26.48) | — |
| (42.25%) | (37.28%) | (49.03%) | (43.65%) | 0.00% | (75.58%) | 0.00% | 44.97% | 0.00% | 0.00% | |
| (27.89%) | (25.87%) | (37.04%) | (34.10%) | 0.00% | (9.01%) | 0.00% | (110.57%) | 0.00% | 0.00% | |
ROIC |
(118.73%) | (58.09%) | (106.30%) | (137.79%) | 0.00% | (484.73%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(38.42%) | (44.23%) | (62.97%) | (50.05%) | (47.04%) | (6.80%) | (6.47%) | (471.63%) | (471.63%) | 0.00% |
Average Days of Receivables |
100.01 | 92.49 | 74.32 | 73.03 | 73.03 | 69.63 | 69.63 | 45.39 | 45.39 | 0.00 |
Research and Development Expense of Revenue |
37.15% | 46.07% | 84.39% | 119.97% | 120.02% | 119.01% | 119.01% | 107.54% | 107.54% | 177.41% |
Selling, General and Administrative Expense of Revenue |
87.19% | 99.17% | 134.58% | 186.80% | 194.31% | 216.29% | 205.18% | 109.53% | 106.98% | 117.71% |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
24.01% | 25.63% | 41.70% | 57.95% | 0.00% | 76.40% | 0.00% | 23.79% | 0.00% | 21.89% |
Graham Net Nets |
0.16 | 0.16 | 0.68 | 0.57 | 0.33 | 0.33 | (3.55) | (3.44) | (6.85) | (6.85) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 190.06 | 0.00 | 0.00 |
Earnings Yield |
(8.16%) | (10.58%) | (61.32%) | (35.90%) | (2.51%) | (2.57%) | (140.31%) | (135.77%) | 0.00% | 0.00% |
Free Cash Flow Yield |
(1.71%) | (6.72%) | (48.04%) | (40.06%) | (16.55%) | (16.95%) | (72.48%) | (70.14%) | 0.00% | 0.00% |
Revenue per Share |
0.40 | 0.39 | 0.32 | 0.37 | 0.37 | 0.36 | 0.36 | 7.64 | 7.64 | 4.72 |
Operating CF per Share |
(0.05) | (0.20) | (0.48) | (0.85) | (0.85) | (1.09) | (1.09) | (13.49) | (13.73) | (20.63) |
Capex per Share |
(0.01) | (0.01) | (0.03) | (0.09) | 0.00 | (0.05) | 0.00 | (0.39) | 0.00 | (0.77) |
Free Cash Flow per Share |
(0.06) | (0.21) | (0.51) | (0.94) | (0.85) | (1.13) | (1.09) | (13.88) | (13.73) | (21.39) |
Cash per Share |
0.61 | 0.42 | 0.65 | 1.19 | 1.19 | 2.43 | 2.43 | 9.94 | 9.94 | 0.00 |
Shareholders Equity per Share |
0.79 | 0.80 | 1.07 | 1.63 | 1.63 | 2.58 | 2.58 | (59.75) | (0.16) | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.79 | 0.80 | 1.07 | 1.63 | 1.63 | 2.58 | 2.58 | (59.75) | (0.16) | 0.00 |
Free Cash Flow |
(16.05) | (44.36) | (104.59) | (187.36) | (169.11) | (197.06) | (189.24) | (84.08) | (83.17) | (124.90) |
Working Capital |
183.99 | 144.40 | 186.99 | 305.81 | 305.81 | 462.08 | 462.08 | 27.64 | 27.64 | — |
Capital Expenditures |
(3.35) | (2.66) | (5.77) | (18.24) | (18.30) | (7.88) | (7.88) | (2.38) | (2.38) | (4.47) |
Net Current Asset Value |
148.55 | 105.36 | 147.04 | 264.93 | 264.93 | 387.63 | 387.63 | (411.79) | (50.85) | 0.00 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.03 | 0.09 | 0.25 | 0.00 | 0.13 | 0.00 | 0.05 | 0.00 | 0.16 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.49 | 0.53 | 0.42 | 0.19 | 0.11 | 0.14 | 0.05 | 0.19 | 0.19 | 0.00 |
Cash ROIC |
(4.63%) | (17.22%) | (29.51%) | (33.27%) | (28.50%) | (22.64%) | (21.07%) | 33.92% | (73.53%) | 0.00% |
Accounts Receivable Turnover |
4.11 | 4.80 | 4.69 | 5.51 | 0.00 | 7.07 | 0.00 | 8.04 | 0.00 | 0.00 |
Accounts Payable Turnover |
10.70 | 7.11 | 7.97 | 5.22 | 0.00 | 4.10 | 0.00 | 6.55 | 0.00 | 0.00 |
Inventory Turnover |
0.78 | 0.46 | 0.74 | 0.71 | 0.00 | 1.47 | 0.00 | 3.97 | 0.00 | 0.00 |
Average Days of Payables |
38.29 | 46.69 | 37.88 | 77.57 | 77.57 | 46.50 | 44.96 | 55.70 | 55.09 | 0.00 |
Days of Inventory on Hand |
431.93 | 777.67 | 543.45 | 645.12 | 1,023.59 | 290.67 | 494.34 | 87.64 | 95.33 | 0.00 |
Average Receivables |
23.77 | 17.11 | 14.05 | 13.31 | 13.31 | 8.84 | 8.84 | 5.75 | 5.75 | — |
Average Payables |
4.85 | 4.67 | 6.15 | 6.50 | 6.50 | 11.10 | 11.10 | 16.40 | 16.40 | — |
Average Inventory |
66.09 | 71.91 | 66.50 | 48.11 | 65.70 | 31.02 | 44.77 | 27.09 | 27.09 | — |
Average Assets |
276.31 | 280.18 | 360.92 | 494.77 | 494.77 | 359.58 | 359.58 | 147.19 | 73.60 | 0.00 |
Average Common Equity |
182.41 | 194.44 | 272.71 | 386.53 | 386.53 | 42.88 | 42.88 | (361.93) | (361.93) | — |
Columns are period end dates